Publication: Ulcerative colitis: Gut microbiota, immunopathogenesis and application of natural products in animal models.
dc.contributor.author | Nascimento, Roberto de Paula do | |
dc.contributor.author | Machado, Ana Paula da Fonseca | |
dc.contributor.author | Galvez, Julio | |
dc.contributor.author | Cazarin, Cinthia Baú Betim | |
dc.contributor.author | Maróstica Junior, Mario Roberto | |
dc.date.accessioned | 2023-02-09T09:37:29Z | |
dc.date.available | 2023-02-09T09:37:29Z | |
dc.date.issued | 2020-07-25 | |
dc.description.abstract | Ulcerative colitis (UC) is an inflammatory bowel disease with increasing incidence in the world, especially in developing countries. Although knowledge of its pathogenesis has progressed over the last years, some details require clarification. Studies have highlighted the role of microbial dysbiosis and immune dysfunction as essential factors that may initiate the typical high-grade inflammatory outcome. In order to better understand the immunopathophysiological aspects of UC, experimental murine models are valuable tools. Some of the most commonly used chemicals to induce colitis are trinitrobenzene sulfonic acid, oxazolone and dextran sodium sulfate. These may also be used to investigate new ways of preventing or treating UC and therefore improving targeting in human studies. The use of functional foods or bioactive compounds from plants may constitute an innovative direction towards the future of alternative medicine. Considering the above, this review focused on updated information regarding the 1. gut microbiota and immunopathogenesis of UC; 2. the most utilized animal models of the disease and their relevance; and 3. experimental application of natural products, not yet tested in clinical trials. | |
dc.identifier.citation | Nascimento RPD, Machado APDF, Galvez J, Cazarin CBB, Maróstica Junior MR. Ulcerative colitis: Gut microbiota, immunopathogenesis and application of natural products in animal models. Life Sci. 2020 Oct 1;258:118129. | |
dc.identifier.doi | 10.1016/j.lfs.2020.118129 | |
dc.identifier.essn | 1879-0631 | |
dc.identifier.pmid | 32717271 | |
dc.identifier.unpaywallURL | https://doi.org/10.1016/j.lfs.2020.118129 | |
dc.identifier.uri | http://hdl.handle.net/10668/16005 | |
dc.journal.title | Life sciences | |
dc.journal.titleabbreviation | Life Sci | |
dc.language.iso | en | |
dc.organization | Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA) | |
dc.page.number | 118129 | |
dc.pubmedtype | Journal Article | |
dc.pubmedtype | Review | |
dc.relation.publisherversion | https://www.sciencedirect.com/science/article/pii/S0024320520308808?via%3Dihub | |
dc.rights.accessRights | open access | |
dc.subject | Bioactive compounds | |
dc.subject | Dextran sodium sulfate | |
dc.subject | Functional foods | |
dc.subject | Inflammation | |
dc.subject | Inflammatory bowel diseases | |
dc.subject | Microbiota | |
dc.subject | Natural products | |
dc.subject | Oxazolone | |
dc.subject | Trinitrobenzene sulfonic acid | |
dc.subject.decs | Colitis Ulcerosa | |
dc.subject.decs | Disbiosis | |
dc.subject.decs | Modelos Animales de Enfermedad | |
dc.subject.decs | Microbiota Intestinal | |
dc.subject.decs | Compuestos Bioactivos | |
dc.subject.decs | Compuestos Bioactivos | |
dc.subject.mesh | Animals | |
dc.subject.mesh | Biological Products | |
dc.subject.mesh | Colitis, Ulcerative | |
dc.subject.mesh | Disease Models, Animal | |
dc.subject.mesh | Gastrointestinal Microbiome | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Models, Biological | |
dc.title | Ulcerative colitis: Gut microbiota, immunopathogenesis and application of natural products in animal models. | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 258 | |
dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- RISalud_Accesorestringido.pdf
- Size:
- 93.39 KB
- Format:
- Adobe Portable Document Format